Navigation Links
Lower contrast agent dose feasible in 320 row CT angiography
Date:9/30/2011

The analysis of 180 CT angiography studies done using a 320 detector row CT scanner found that a contrast media protocol based on 60 milliliters of iopamidol "had sufficient enhancement in more than 96% of coronary segments," said Frank Rybicki, MD, of Brigham and Women's Hospital in Boston, and one of the authors of the study.

"Many centers currently use a higher iodine load comparable or equal to 80 milliliters of iopamidol," he said. The study shows that "this is not necessary, and the extra contrast means unnecessary costs and increased risk of contrast-induced nephropathy (CIN) to the patients." The risk of CIN is of special concern for these patients because they commonly have a renal insufficiency, which is known major risk factor for CIN, Dr. Rybicki added.

"We analyzed larger patients only (those with a body mass index of more than 30) and found that 92% of coronary segments had sufficient enhancement," said Dr. Rybicki. "These results support the general use of 60 milliliters of iopamidol for CT angiography done on 320 detector row CT scanners," he said.


'/>"/>

Contact: Keri Sperry
ksperry@arrs.org
703-858-4315
American Roentgen Ray Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Cancer screening rates lower among those with fatalistic attitudes
2. Liver cancer incidence lower in patients with nonalcoholic fatty liver disease than hepatitis C
3. Lots of Coffee Might Lower Depression Risk: Study
4. Study to test efficacy of prenatal intervention, support on lowering postpartum depression in teens
5. Liposuction May Lower Certain Blood Fats, Researcher Says
6. IUDs May Lower Womens Risk for Cervical Cancer: Study
7. Study finds hospitals of last resort deliver lower quality of lung cancer care
8. Big Health Plans Can Negotiate Lower Hospital Costs: Study
9. Consolidation of health plans may help lower hospital costs, study finds
10. Alzheimers brains found to have lower levels of key protein
11. Could Lots of Chocolate Lower Your Heart Risk?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 08, 2016 , ... The Dan Carlisle Agency, an Alabama-owned ... is announcing the launch of a charity drive to raise support and awareness ... and children in Birmingham has grown steadily since the 1980’s, and the Pathways ...
(Date:12/8/2016)... Payne, AL (PRWEB) , ... December 08, 2016 ... ... offering insurance and financial consulting services to residential and commercial clients in the ... awareness and support for Nobis Works. , Since 1977, Nobis Works has built ...
(Date:12/7/2016)... VA (PRWEB) , ... December 07, 2016 , ... ... are celebrating the passage of the most comprehensive mental health systems reform legislation ... the support of the President, and the commitment of our elected officials to ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... of Smart Device Remote Control through a new partnership with Splashtop Inc. This ... strengthens its mobile solutions to help businesses maximize their uptime and productivity. , ...
(Date:12/7/2016)... ... December 07, 2016 , ... It is vital for any lab to secure ... data. The team at Beckman Coulter has designed Kaluza, templates with advanced analytical tools ... need to operate in a GLP (Good Laboratory Practice) fashion. , With features designed ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016  Haemonetics Corporation (NYSE: HAE ) has ... an innovative software suite designed to help customers drive efficiency ... of NextGen DMS 4 improves core features and introduces innovations ... liter of plasma collected, enhancing quality and regulatory compliance and ... ...
(Date:12/8/2016)... SINGAPORE , BEIJING , and ... a leading commercial provider of genomic services and solutions with ... a Singapore biotechnology company; and the ... today that NovogeneAIT Genomics Singapore (NovogeneAIT) – a new joint ... whole genome sequencing (WGS) centre at Biopolis, Singapore ...
(Date:12/7/2016)... Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial & ... biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar version ... Japan , Kenya , Czech ... , China , Slovakia , ... 2 diabetes mellitus. The patent on Lantus expired in 2014. Lantus ...
Breaking Medicine Technology: